Natural progression of renal function in the elderly: Analysis of poor prognosis factors associated with chronic kidney disease;Evolución natural de la función renal en el anciano: Análisis de factores de mal pronóstico asociados a la enfermedad renal crónica

Nefrologia

Volumn 33, Issue 4, 2013, Pages 462-469

  Heras, Manuel ^a   García Cosmes, Pedro ^b   Fernández Reyes, María J ^a   Sánchez, Rosa ^a  

^a HOSPITAL GENERAL DE SEGOVIA   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Acute renal failure; Elderly people; Heart failure; Proteinuria; Renal function; Uric acid

Indexed keywords

AGE; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; DISEASE COURSE; HUMAN; PROGNOSIS; PROTEINURIA;

AGE FACTORS; AGED; DISEASE PROGRESSION; HUMANS; PROGNOSIS; PROTEINURIA; RENAL INSUFFICIENCY, CHRONIC;

EID: 84883016083     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2013.Jan.11806     Document Type: Article

References (52)

1. Goldstein RS, Tarloff JB, Hook JB. Age-related nephropathy in laboratory rats. FASEB J 1988;2:2241-51.
2. Anderson S, Brenner BM. Effects of aging on the renal glomerulus. Am J Med 1986;80:435-42.
3. Kaysen GA, Myers BD. The aging kidney. Clin Geriatr Med 1985;1:207-22.
4. Fliser D, Zeier M, Nowack R, Ritz E. Renal functional reserve in healthy elderly subjects. J Am Soc Nephrol 1993;3:1371-7.
5. Fliser D, Franek E, Joest M, Block S, Mutschler E, Ritz E. Renal function in the elderly: impact of hypertension and cardiac function. Kidney Int 1997;51:1196-204.
6. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985;33:278-85.
7. Fliser D, Franek E, Ritz E. Renal function in the elderly-is the dogma of an inexorable decline of renal function correct. Nephrol Dial Transplant 1997;12:1553-5.
8. National Kidney Foundation. K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S1-S266.
9. Heras M, Fernández-Reyes MJ, Sánchez R, Guerrero MT, Molina A, MA Rodríguez, et al. Ancianos con enfermedad renal crónica: qué ocurre a los cinco años de seguimiento. Nefrologia 2012;32:300-5.
10. Keith D, Nichols GA, Gullion C, Brown JB, Smith DH. Longitudinal follow-up and outcome among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004;164:659-63.
11. Eriksen BO, Ingebretsen OC. The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int 2006;69:375-82.
12. García de Vinuesa S. Factores de progresión de la enfermedad renal crónica. Prevención secundaria. Nefrologia 2008;S3:17-21.
13. Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, et al. Blood pressure control, proteinuria, and the progression of renal disease: the Modification of Diet In Renal Disease Study. Ann Intern Med 1995;123:754-62.
14. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001;286:421-6.
15. Gansevoort RT, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, et al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int 2011;80:93-104.
16. Heras M, Fernández-Reyes MJ, Guerrero MT, Sánchez R, Molina A, Rodríguez A, et al. Seguimiento durante 36 meses de la función renal en el anciano. Dial Transpl 2011;32:97-101.
17. Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Jindal KK, et al. Relation between kidney function, proteinuria and adverse outcomes. JAMA 2010;303:423-9.
18. Abdel-Kader K, Palevsky P. Acute kidney injury in the elderly. Clin Geriatr Med 2009;25:331-58.
19. Rosner MH. The pathogenesis of susceptibility to acute kidney injury in the elderly. Curr Aging Sci 2009;2:158-64.
20. Yilmaz R, Erden Y. Acute kidney injury in the elderly population. Int Urol Nephrol 2010;42:259-71.
21. Anderson S, Eldadah B, Halter JB, Hazzard WR, Himmelfard J, McFarland Horne, et al. Acute kidney injury in older adults. J Am Soc Nephrol 2011;22:28-38.
22. Hsu CY. Where is the epidemic kidney disease. J Am Soc Nephrol 2010;21:1607-11.
23. Schmitt R, Coca S, Kanbay M, Tinetti ME, Cantley LG, Parikh CR. Recovery of kidney function after acute kidney injury in the elderly: A systematic review and meta-analysis. Am J Kidney Dis 2008;52:262-71.
24. Lo LJ, Go AS, Chertow GM, McCulloch CE, Fan D, Ordonez JD, et al. Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int 2009;76:893-9.
25. Chawla LS, Amdur RL, Amodeo S, Kimmel PL, Palant CE. The severity of acute kidney injury predicts progression to chronic kidney disease. Kidney Int 2011;79:1361-9.
26. Ishani A, Nelson D, Clothier B, Schult T, Nugent S, Greer N, et al. The magnitude of acute serum creatinine increase after cardiac surgery and the risk of chronic kidney disease, progression of kidney disease, and death. Arch intern Med 2011;171:226-33.
27. Thakar CV, Christianson A, Himmelfarb J, Leonard AC. Acute kidney injury episodes and chronic kidney disease risk in diabetes mellitus. Clin J Am Soc Nephrol 2011;6:2567-72.
28. Coca SG, King JT, Rosenthal RA, Perkal MF, Parikh CR. The duration of postoperative acute kidney injury is an additional parameter predicing long-term survival in diabetic veterans. Kidney Int 2010;78:926-33.
29. Brown JR, Kramer RS, Coca SG, Parikh CR. Duration of acute kidney injury impacts long-term survival after cardiac surgery. Ann Thorac Surg 2010;90:1142-8.
30. Ishani A, Xue JL, Himmelfarb J, Eggers PW, Kimmel PL, Molitoris BA, et al. Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol 2009;20:223-8.
31. Bucaloiu ID, Kirchner HL, Norfolk ER, Hartle JE, Perkins RM. Increased risk of death and novo chronic kidney disease following reversible acute kidney injury. Kidney Int 2012;81:477-85.
32. Heras M, Fernández-Reyes MJ, Guerrero MT, Sánchez R, Muñoz A, Molina A, et al. Factores predictores de fracaso renal agudo en ancianos con enfermedad renal crónica. Nefrologia 2012;32:819-23.
33. Biernacka A, Frangogiannis NG. Aging and cardiac fibrosis. Aging Dis 2011;2:158-73.
34. Chivite D, Formiga F, Pujol R. La insuficiencia cardiaca en el paciente anciano. Rev Clin Esp 2011;211:26-35.
35. Olivetti G, Melissari M, Capasso JM, Anversa P. Cardiomyopathy of the aging human Heart. Myocite loss and reactive cellular hypertrophy. Circ Res 1991;68:1560-8.
36. Gazoti Debessa CR, Mesiano Maifrino LB, Rodrigues de Souza R. Age related changes of the collagen network of the human heart. Mech Ageing Dev 2001;122:1049-58.
37. Heras M, Fernández-Reyes MJ, Sánchez R, Guerrero MT. Función renal en el anciano y su asociación con la comorbilidad. Nefrologia 2009;29:84-5.
38. Minguela JI, Hernando A, Gallardo I, Martínez I, García P, Muñoz RI, et al. La hiperuricemia como factor de riesgo cardiovascular y renal. Dial Transplant 2011;32:57-61.
39. Johnson RJ, Kang D-H, Feig D, Kivlighn S, Kanellis J, Watanabe S, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease. Hypertension 2003;41:1183-90.
40. Nashar K, Fried LF. Hyperuricemia and the progresión of chronic kidney disease: is uric acid a marker or an independent risk factor. Adv Chronic Kidney Dis 2012;19:386-91.
41. Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS. Uric acid and incident kidney disease in the community. J Am Soc Nephrol 2008;19:1204-11.
42. Obermayr RP, Temml C, Gutjahr G, Knechtelsdorfer M, Oberbauer R, Klauser-Braun R. Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol 2008;19:2407-13.
43. Lapsia V, Johnson RJ, Dass B, Shimada M, Kambhampati G, Ejaz NI, et al. Elevated uric acid increases the risk for acute kidney injury. Am J Med 2012;125:302.e9-17.
44. Ejaz AA, Kambhampati G, Ejaz NI, Dass B, Lapsia V, Arif AA, et al. Post-operative serum uric acid and acude kidney injury. J Nephrol 2012;25:497-505.
45. Chiou WK, Huang DH, Wang MH, Lee YJ, Lin JD. Significance and association of serum uric acid (UA) levels with components of metabolic syndrome (MS) in the elderly. Arch Gerontol Geriatr 2012;55:724-8.
46. Zoppini G, Targher G, Chonchol M, Ortalda V, Abaterusso C, Pichiri I, et al. Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function. Diabetes Care 2012;35:99-104.
47. Zhang L, Wang F, Wang X, Liu L, Wang H. The association between plasma uric acid and renal function decline in a Chinese population-based cohort. Nephrol Dial Transplant 2012;27:1836-9.
48. Goicoechea M, García de Vinuesa S, Verdalles V, Ruiz-Caro C, Ampuero J, Rincón A, et al. Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol 2010;5:1388-93.
49. Yelken B, Caliskan Y, Gorgulu N, Altun I, Yilmaz A, Yazici H, et al. Reduction of uric acid levels with allopurinol improves endotelial function in patients with chronic kidney disease. Clin Nephrol 2012;77:275-82.
50. Madero M, Sarnak MJ, Wang X, Greene T, Beck GJ, Kusek JW, et al. Uric acid and long term outcomes in CKD. Am J Kidney Dis 2009;53:796-803.
51. Kuo CF, See LC, Yu KH, Chou IJ, Chiou MJ, Luo SF. Significance of serum uric acid levels on the risk of all cause and cardiovascular mortality. Rheumatology (Oxford) 2013;52(1):127-34.
52. Heras M, Fernández-Reyes MJ, Sánchez R, Molina A, Rodríguez A, Álvarez-Ude F. Utilidad del ácido úrico como marcador de mortalidad global en una cohorte de ancianos. Nefrologia 2012;32:67-72.